IP Library › Granted Patent US 8,067,201
Granted Patent B2
US 8,067,201 · App. 12/763,168 · Granted Nov 29, 2011

Methods for protein refolding

Assignee: Bristol-Myers Squibb Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,201
App. No.
12/763,168
Granted
Nov 29, 2011
Kind
B2
Abstract

Provided herein are methods for refolding proteins. The methods involve covalently modifying a denatured protein with a nonproteinaceous polymer and then renaturing the modified protein.

Claims (44)

1. A method for refolding a protein comprising covalently modifying a denatured protein with a nonproteinaceous polymer and renaturing the covalently modified protein, wherein the method comprises removing the nonproteinaceous polymer after renaturing the covalently modified protein.

2. The method of claim 1 , wherein the nonproteinaceous polymer is polyethylene glycol (PEG) polymer.

3. The method of claim 2 , wherein the PEG has a molecular weight of 20 kDa to 80 kDa.

4. The method of claim 2 , wherein the PEG is linear.

5. The method of claim 2 , wherein the PEG is branched.

6. The method of claim 1 , wherein the nonproteinaceous polymer is attached to the protein through a cleavable linker.

7. The method of claim 1 , wherein the protein is covalently modified with the nonproteinaceous polymer at a site specific location.

8. The method of claim 2 , wherein the PEG is covalently attached to the protein at a cysteine residue.

9. The method of claim 1 , wherein the denatured protein was expressed in bacterial cells.

10. The method of claim 9 , wherein the bacterial cells are E. coli.

11. The method of claim 9 , wherein the denatured protein was isolated from inclusion bodies.

12. The method of claim 1 , wherein the protein was denatured by addition of detergents, or chaotropic agents.

13. The method of claim 12 , wherein the disulfide bonds of the protein were chemically cleaved.

14. The method of claim 12 , wherein the protein was denatured using a chaotropic agent.

15. The method of claim 14 , wherein the protein is renatured by removing the chaotropic agent.

16. The method of claim 15 , wherein the chaotropic agent is removed using dialysis.

17. The method of claim 1 , wherein the protein comprises a tenth fibronectin Type III ( 10 Fn3) domain.

18. The method of claim 17 , wherein the protein comprises two 10 Fn3 domains.

19. A method for producing a protein, comprising:

a) expressing a recombinant protein in bacterial cells,

b) isolating the recombinant protein from inclusion bodies,

c) covalently modifying the recombinant protein with PEG,

d) renaturing the pegylated recombinant protein, and

e) removing the PEG from the recombinant protein.

20. The method of claim 19 , wherein the recombinant protein comprises a tenth fibronectin Type III ( 10 Fn3) domain.

21. A method for refolding a protein comprising covalently modifying a denatured protein with a nonproteinaceous polymer and renaturing the covalently modified protein, wherein the nonproteinaceous polymer is attached to the protein through a protease cleavable linker.

22. The method of claim 21 , wherein the nonproteinaceous polymer is polyethylene glycol (PEG) polymer.

23. The method of claim 21 , wherein the protein comprises a tenth fibronectin Type III ( 10 Fn3) domain.

24. A method for producing a pegylated protein, comprising:

a) expressing a recombinant protein in bacterial cells,

b) isolating the recombinant protein from inclusion bodies,

c) covalently modifying the recombinant protein with PEG, and

d) renaturing the pegylated recombinant protein,

wherein the PEG is attached to the recombinant protein through a protease cleavable linker.

25. The method of claim 24 , wherein the recombinant protein comprises a tenth fibronectin Type III ( 10 Fn3) domain.

26. A method for producing a pegylated protein, comprising:

a) expressing a recombinant protein in bacterial cells,

b) isolating the recombinant protein from inclusion bodies,

c) exposing the recombinant protein to a chaotropic agent,

d) covalently modifying the recombinant protein with PEG,

e) renaturing the pegylated recombinant protein by removing the chaotropic agent,

f) purifying the refolded, pegylated, recombinant protein, and

g) removing the PEG from the recombinant protein.

27. The method of claim 26 , wherein the recombinant protein comprises a tenth fibronectin Type III ( 10 Fn3) domain.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2010
From: MORIN, PAUL; LIN, ZHENG
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 024643/0923 →
Continuity (2)
Provisional Application 61212990 · Apr 17, 2009
Related Publication 20100273216A1 · Oct 28, 2010